全球生物製程市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球生物製程市場預計將從2025年的735億美元成長至2034年的2,433.9億美元，2026年至2034年的複合年成長率（CAGR）為14.23%。該市場正經歷強勁成長，主要得益於生物製藥、疫苗、生物相似藥和先進治療產品的產量增加。生物製程是指在藥品和生物技術產品的生產過程中使用生物系統和技術。對生物製藥日益成長的需求以及對生物製藥研發投入的增加是市場擴張的主要驅動力。醫療保健產業對創新治療方法的關注為生物製程技術創造了巨大的機會。

上游和下游製程的技術進步正在提高生產效率、擴充性和產品品質。一次性系統、自動化平台和先進的分析技術正在推動更有效率的生產營運。製藥和生物技術公司正在擴大產能，以滿足日益成長的生物製藥和個人化療法需求。監管機構對品質和一致性的重視也推動了先進生物製程解決方案的應用。

隨著全球生物技術創新持續加速發展，前景極為光明。基因療法、細胞療法和再生醫學等新興治療方法將對先進的生物製程技術產生顯著需求。對靈活生產設施和數位化生物製程系統的投資將進一步推動市場成長。隨著生物製藥在醫療保健領域的重要性日益凸顯，生物製程市場預計將在長期內持續擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物製程市場：依產品分類

• 市場分析、洞察與預測
• 生技藥品安全性檢測（內毒素檢測、無菌檢測、病毒安全性檢測）
• 細胞培養（哺乳動物細胞培養、微生物細胞培養、昆蟲細胞培養）
• 細胞增殖（手動細胞增殖、自動細胞增殖）
• 細胞株開發（融合瘤技術、重組細胞株開發）
• 流式細胞技術（細胞分選、細胞分析）
• 切向流過濾（微過濾、超過濾）

第5章 全球生物製程市場：依應用分類

• 市場分析、洞察與預測
• 抗生素
• 生物相似藥
• 重組蛋白
• 其他用途

第6章 全球生物製程市場：依最終用途分類

• 市場分析、洞察與預測
• 生物製藥公司
• 契約製造組織
• 學術研究機構
• 食品和飼料業
• 受委託的研究機構

第7章 全球生物製程市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group AG
  • GE Healthcare
  • Waters Corporation
  • STADA Arzneimittel AG
  • Bio-Rad Laboratories Inc
  • Applikon Biotechnology BV
  • Agilent Technologies Inc
  • Solida Biotech GmbH
  • Fujifilm Healthcare Corporation
  • Catalent Inc
  • Asahi Kasei Medical Inc

The global bioprocessing market size is expected to reach USD 243.39 Billion in 2034 from USD 73.50 Billion in 2025, growing at a CAGR of 14.23 during 2026-2034.This market is witnessing robust growth due to increasing production of biologics, vaccines, biosimilars, and advanced therapeutic products. Bioprocessing involves the use of biological systems and technologies for manufacturing pharmaceutical and biotechnology products. Rising demand for biologic medicines and growing investments in biopharmaceutical research are major factors driving market expansion. The healthcare industry's focus on innovative treatments is creating significant opportunities for bioprocessing technologies.

Technological advancements in upstream and downstream processing are improving productivity, scalability, and product quality. Single-use systems, automation platforms, and advanced analytics are enabling more efficient manufacturing operations. Pharmaceutical and biotechnology companies are expanding production capacities to meet rising demand for biologics and personalized therapies. Regulatory emphasis on quality and consistency is also encouraging adoption of advanced bioprocessing solutions.

Future prospects remain highly promising as biotechnology innovation continues accelerating worldwide. Emerging therapies such as gene therapy, cell therapy, and regenerative medicine will generate substantial demand for sophisticated bioprocessing technologies. Investments in flexible manufacturing facilities and digital bioprocessing systems will further support growth. As biologics become increasingly important in healthcare, the bioprocessing market is expected to experience long-term expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Biologics Safety Testing (Endotoxin Testing, Sterility Testing, Viral Safety Testing)
• Cell Culture (Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture)
• Cell Expansion (Manual Cell Expansion, Automated Cell Expansion)
• Cell Line Development (Hybridoma Technology, Recombinant Cell Line Development)
• Flow Cytometry (Cell Sorting, Cell Analysis)
• Tangential Flow Filtration (Microfiltration, Ultrafiltration)

By Application

• Antibiotics
• Biosimilars
• Recombinant Proteins
• Other Applications

By End Use

• Biopharmaceutical Companies
• Contract Manufacturing Organization
• Academic Research Institutes
• Food and Feed Industry
• Contract Research Organization

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG, GE Healthcare, Waters Corporation, STADA Arzneimittel AG, Bio-Rad Laboratories Inc., Applikon Biotechnology B.V., Agilent Technologies Inc., Solida Biotech GmbH, Fujifilm Healthcare Corporation, Catalent Inc., Asahi Kasei Medical Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPROCESSING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Biologics Safety Testing (Endotoxin Testing, Sterility Testing, Viral Safety Testing) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cell Culture (Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cell Expansion (Manual Cell Expansion, Automated Cell Expansion) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell Line Development (Hybridoma Technology, Recombinant Cell Line Development) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Flow Cytometry (Cell Sorting, Cell Analysis) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Tangential Flow Filtration (Microfiltration, Ultrafiltration) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPROCESSING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biosimilars Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPROCESSING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Contract Manufacturing Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Food and Feed Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPROCESSING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPROCESSING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Sartorius AG
  • 9.2.3 Merck KGaA
  • 9.2.4 Danaher Corporation
  • 9.2.5 Lonza Group AG
  • 9.2.6 GE Healthcare
  • 9.2.7 Waters Corporation
  • 9.2.8 STADA Arzneimittel AG
  • 9.2.9 Bio-Rad Laboratories Inc
  • 9.2.10 Applikon Biotechnology B.V
  • 9.2.11 Agilent Technologies Inc
  • 9.2.12 Solida Biotech GmbH
  • 9.2.13 Fujifilm Healthcare Corporation
  • 9.2.14 Catalent Inc
  • 9.2.15 Asahi Kasei Medical Inc